RIP2 Antikörper (N-Term)
-
- Target Alle RIP2 Antikörper anzeigen
- RIP2 (ROP Interactive Partner 2 (RIP2))
-
Bindungsspezifität
- N-Term
- Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser RIP2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Kreuzreaktivität
- Maus, Ratte (Rattus)
- Produktmerkmale
- Purified IgG
- Aufreinigung
- Purified
- Isotyp
- IgG
- Top Product
- Discover our top product RIP2 Primärantikörper
-
anti-ROP Interactive Partner 2 (RIP2) (Tyr397) antibody
RIP2 Reaktivität: Human, Maus WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-ROP Interactive Partner 2 (RIP2) (pSer176) antibodyRIP2 Reaktivität: Human, Maus WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-ROP Interactive Partner 2 (RIP2) (AA 401-540) antibodyRIP2 Reaktivität: Human, Maus WB, ELISA, IHC (p), IHC (fro), IF (p), IF (cc) Wirt: Kaninchen Polyclonal unconjugated
anti-ROP Interactive Partner 2 (RIP2) (AA 1-322) antibodyRIP2 Reaktivität: Human WB Wirt: Ratte Monoclonal Nick-1 unconjugated
anti-ROP Interactive Partner 2 (RIP2) (C-Term) antibodyRIP2 Reaktivität: Human, Maus, Ratte WB Wirt: Kaninchen Polyclonal unconjugated
anti-ROP Interactive Partner 2 (RIP2) (pSer176) antibodyRIP2 Reaktivität: Human, Maus WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-ROP Interactive Partner 2 (RIP2) (Ser176) antibodyRIP2 Reaktivität: Human, Maus WB, ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
-
- Target
- RIP2 (ROP Interactive Partner 2 (RIP2))
- Andere Bezeichnung
- RIP2 (RIP2 Produkte)
- Hintergrund
- Synonyms: RICK
- Gen-ID
- 8767
- UniProt
- O43353
- Pathways
- T-Zell Rezeptor Signalweg, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Immune Effector Process, Toll-Like Receptors Cascades
-
